U.S., Nov. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07935616) titled 'Zileuton for Food Allergy' on Oct. 27.
Brief Summary: Our proposed project will seek to determine if an oral medication called zileuton, which blocks the synthesis of inflammatory molecules called leukotrienes that are involved in allergic reactions, may be able to decrease absorption of food allergens and prevent severe food allergy reactions from occurring. Our study will measure levels of peanut in the blood before and after subjects consume an allergen they can tolerate and compare the results with and without administration of the study medication, zileuton. If our study shows that zileuton can decrease the absorption of a food...